Thyroid Immune-Related Adverse Events in Patients with Cancer Treated with anti-PD1/anti-CTLA4 Immune Checkpoint Inhibitor Combination: Clinical Course and Outcomes.
Endocr Pract
; 27(9): 886-893, 2021 Sep.
Article
in En
| MEDLINE
| ID: mdl-33581327
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thyroid Diseases
/
Immune Checkpoint Inhibitors
/
Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Endocr Pract
Journal subject:
ENDOCRINOLOGIA
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: